Literature DB >> 22219180

GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy.

Mingyue Han1, Zhi Yang, Danish Sayed, Minzhen He, Shumin Gao, Lin Lin, Seonghun Yoon, Maha Abdellatif.   

Abstract

AIMS: GATA4 is a transcription factor that is up-regulated during cardiac hypertrophy and plays a fundamental role in myocyte growth and survival. In this study, we investigate the transcriptional vs. post-transcriptional mechanisms that are involved in regulating GATA4 in the heart during neonatal and pressure overload-induced hypertrophic growth. METHODS AND
RESULTS: GATA4 protein is significantly higher during pressure overload-induced (2.9 ± 0.4-fold) and neonatal (6.8 ± 1-fold) hypertrophic growth vs. the normal adult mouse heart. Using RNA polymerase II immunoprecipitation combined with deep sequencing, we confirmed that active transcription of the Gata4 gene remained unchanged during hypertrophy, whereas it was two-fold higher in the neonatal vs. adult heart, commensurate with the mRNA levels. These results suggested a post-transcriptional mode of regulation of its expression, which prompted the identification of a conserved sequence in its 3'-untranslated region that was responsible for reduced translation via miR-26b. Overexpression of miR-26b reduced GATA4-dependent transcription, endothelin-induced hypertrophy, and sensitized the cells to apoptotic insults. Additionally, miR-26b targeted phospholipase C-β1, which, in turn, inhibited miR-26b expression, creating a double-negative feedback loop. Accordingly, overexpression of miR-26b in the heart inhibited up-regulation of its targets and the development of hypertrophy. However, knockdown of miR-26b is not sufficient for inducing hypertrophy.
CONCLUSION: Down-regulation of miR-26b in the heart is required for the up-regulation of GATA4 and the induction of pressure-induced cardiac hypertrophy. The results also underscore the functional relevance of miRNAs in regulating gene expression during cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22219180      PMCID: PMC3291090          DOI: 10.1093/cvr/cvs001

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  26 in total

1.  C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Authors:  Pontus Boström; Nina Mann; Jun Wu; Pablo A Quintero; Eva R Plovie; Daniela Panáková; Rana K Gupta; Chunyang Xiao; Calum A MacRae; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.

Authors:  C T Kuo; E E Morrisey; R Anandappa; K Sigrist; M M Lu; M S Parmacek; C Soudais; J M Leiden
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

4.  Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter.

Authors:  Y Aihara; M Kurabayashi; Y Saito; Y Ohyama; T Tanaka; S Takeda; K Tomaru; K Sekiguchi; M Arai; T Nakamura; R Nagai
Journal:  Hypertension       Date:  2000-07       Impact factor: 10.190

5.  Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

Authors:  T G Parker; S E Packer; M D Schneider
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 6.  MicroRNAs in development and disease.

Authors:  Danish Sayed; Maha Abdellatif
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

7.  Manipulation of adenovirus vectors.

Authors:  F L Graham; L Prevec
Journal:  Methods Mol Biol       Date:  1991

8.  Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators.

Authors:  N S Belaguli; J L Sepulveda; V Nigam; F Charron; M Nemer; R J Schwartz
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths.

Authors:  Danish Sayed; Shweta Rane; Jacqueline Lypowy; Minzhen He; Ieng-Yi Chen; Himanshu Vashistha; Lin Yan; Ashwani Malhotra; Dorothy Vatner; Maha Abdellatif
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

10.  Changes associated with rat heart chromatin during cardiac hypertrophy.

Authors:  J Kamala; M Mariappan; C Rajamanickam
Journal:  Biochem Int       Date:  1986-08
View more
  30 in total

Review 1.  An emerging role for the miR-26 family in cardiovascular disease.

Authors:  Basak Icli; Pranav Dorbala; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2014-06-12       Impact factor: 6.677

2.  In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging.

Authors:  Yingfeng Tu; Lin Wan; Dongliang Zhao; Lihong Bu; Dandan Dong; Zheyu Yin; Zhen Cheng; Baozhong Shen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-07       Impact factor: 9.236

Review 3.  microRNA expression and biogenesis in cellular response to ionizing radiation.

Authors:  Aihong Mao; Yang Liu; Hong Zhang; Cuixia Di; Chao Sun
Journal:  DNA Cell Biol       Date:  2014-06-06       Impact factor: 3.311

Review 4.  Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 5.  Differential expression of microRNAs in different disease states.

Authors:  Maha Abdellatif
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

6.  Impact of miR-26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non-canonical Wnt signalling.

Authors:  Duo Wang; Chang Liu; Yumei Wang; Wenjing Wang; Kang Wang; Xiujuan Wu; Zhigang Li; Cuimei Zhao; Li Li; Luying Peng
Journal:  Cell Prolif       Date:  2017-08-15       Impact factor: 6.831

7.  Transcriptional regulation mediated by H2A.Z via ANP32e-dependent inhibition of protein phosphatase 2A.

Authors:  Hyewon Shin; Minzhen He; Zhi Yang; Yong Heui Jeon; Jessica Pfleger; Danish Sayed; Maha Abdellatif
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-03-08       Impact factor: 4.490

Review 8.  Noncoding RNAs in Cardiac Hypertrophy.

Authors:  Yongqin Li; Yajun Liang; Yujiao Zhu; Yuhui Zhang; Yihua Bei
Journal:  J Cardiovasc Transl Res       Date:  2018-08-31       Impact factor: 4.132

9.  Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.

Authors:  Kristen M Kokkonen-Simon; Amir Saberi; Taishi Nakamura; Mark J Ranek; Guangshuo Zhu; Djahida Bedja; Michaela Kuhn; Marc K Halushka; Dong Ik Lee; David A Kass
Journal:  JCI Insight       Date:  2018-08-09

10.  Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.

Authors:  Darukeshwara Joladarashi; Venkata Naga Srikanth Garikipati; Rajarajan A Thandavarayan; Suresh K Verma; Alexander R Mackie; Mohsin Khan; Anna M Gumpert; Arvind Bhimaraj; Keith A Youker; Cesar Uribe; Sahana Suresh Babu; Prince Jeyabal; Raj Kishore; Prasanna Krishnamurthy
Journal:  J Am Coll Cardiol       Date:  2015-11-17       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.